Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Bavendiek

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 29, 2026
[Digitalis and Heart Failure]Udo Bavendiek, Johann Bauersachs
The New England Journal of Medicine|December 30, 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. ReplyUdo Bavendiek, Annika Großhennig, Johann Bauersachs, et al.
Atherosclerosis|May 19, 2009
Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis?Joanna Jagielska, Gustavo Salguero, Bernhard Schieffer, et al.
European Heart Journal|January 10, 2017
Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failureUdo Bavendiek, Lukas Aguirre Davila, Armin Koch, et al.
Circulation. Cardiovascular Imaging|December 10, 2017
Targeting Cardiovascular Implant Infection: Multimodality and Molecular ImagingJan M Sohns, Udo Bavendiek, Tobias L Ross, et al.
Acute Cardiac Care|August 10, 2013
Dynamic left ventricular outflow tract obstruction: hemodynamic pitfall aheadL Christian Napp, Udo Bavendiek, Joern Tongers, et al.
The Journal of Biological Chemistry|April 30, 2002
Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1Udo Bavendiek, Peter Libby, Meagan Kilbride, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2005
Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cellsUdo Bavendiek, Andreas Zirlik, Samantha LaClair, et al.
BMC Cardiovascular Disorders|November 12, 2016
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla<sup>®</sup> Flex II OccluderJonas Neuser, Muharrem Akin, Udo Bavendiek, et al.
Muscle & Nerve|June 2, 2021
Treatment with patisiran of a patient with hereditary transthyretin-mediated amyloidosis with stage 3 polyneuropathyLars H Müschen, Gudrun Körner, Stefan Gingele, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Deutsche Medizinische Wochenschrift (1946)|May 29, 2026
[Digitalis and Heart Failure]Udo Bavendiek, Johann Bauersachs
The New England Journal of Medicine|December 30, 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. ReplyUdo Bavendiek, Annika Großhennig, Johann Bauersachs, et al.
Atherosclerosis|May 19, 2009
Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis?Joanna Jagielska, Gustavo Salguero, Bernhard Schieffer, et al.
European Heart Journal|January 10, 2017
Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failureUdo Bavendiek, Lukas Aguirre Davila, Armin Koch, et al.
Circulation. Cardiovascular Imaging|December 10, 2017
Targeting Cardiovascular Implant Infection: Multimodality and Molecular ImagingJan M Sohns, Udo Bavendiek, Tobias L Ross, et al.
Acute Cardiac Care|August 10, 2013
Dynamic left ventricular outflow tract obstruction: hemodynamic pitfall aheadL Christian Napp, Udo Bavendiek, Joern Tongers, et al.
The Journal of Biological Chemistry|April 30, 2002
Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1Udo Bavendiek, Peter Libby, Meagan Kilbride, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2005
Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cellsUdo Bavendiek, Andreas Zirlik, Samantha LaClair, et al.
BMC Cardiovascular Disorders|November 12, 2016
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla<sup>®</sup> Flex II OccluderJonas Neuser, Muharrem Akin, Udo Bavendiek, et al.
Muscle & Nerve|June 2, 2021
Treatment with patisiran of a patient with hereditary transthyretin-mediated amyloidosis with stage 3 polyneuropathyLars H Müschen, Gudrun Körner, Stefan Gingele, et al.
Pageof 9